Who we are

Brain and Beer Barcelona is an association of early career researchers in neuroscience, born to promote scientific diffusion and networking between neuroscientists and interested people. BBB organizes and collaborates with all kind of activities from neuroscientific games, cineforums, outreach talks to bring the science to the society like Pint of Science, to congresses for young neuroscientists and much more. Its members are young neuroscientists who carry out their research studying such disparate subjects such as mitochondria, Parkinson's, optopharmacology, molecular mechanisms of memory, glial cells and rare diseases, among others.


Would you like to join us? Send us an e-mail!

Macarena Gómez de Salazar Honrubia

PhD student at IDIBELL (iGluRs Lab- Dr. Altafaj)

Projet: Role of NMDA Receptors Phosphorylation in Cognitive Dysfunctions

@macagsh


Sandra Franco Iborra

PhD student at VHIR (Neurodegenerative disease - Dr. Miquel Vila).

Project: Mitochondrial dysfunction in Parkinson’s disease

@sandrafranib

Marc López Cano

PhD student at UB (Neuropharmacology and pain - Dr. Francisco Ciruela).

Projet: Optopharmacological modulation of mGlu5 receptor in neurodegenerative disorders and pain.

@MarcLopezCano

Pablo Ranea Robles

Postdoctoral scientist at IDIBELL (Neurometabolic Diseases Group - Dra. Aurora Pujol)

Project: Redox metabolism and bioenergetics in X-ALD

@pranea

Xabier Elorza VIDAL

PhD student at CCFF II, UB – IDIBELL (R. Estévez group)

Project: Chloride channel subunits and associated disease Megalencephalic Leukoencephalopathy

@ElviXabi

Patrizia Bianchi

Postdoctoral scientist at Institut de Neurociències-UAB (A. Quintana Group)

Project: Dissecting neuronal susceptibility to mitochondrial disease

Eva Serrano CANDELAS

Postdoctoral scientist at Universitat de Barcelona-Fundació Clínic per a la Recerca Biomèdica (Inmunobiology Group-Dra. Margarita Martín)

Project: Regulation of the expression and function of KIT and PDGFRA by the adaptor molecule 3BP2. Involvement in mast cell differentiation and migration and in pathology.

Project: Study of Omalizumab’s mechanism of action in Chronic Urticaria (CU)